Alcresta Therapeutics, Inc.  

Newton,  MA 
United States
http://www.alcresta.com
  • Booth: 1905

Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases.

The company’s lead product, RELiZORB™, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). 


 Additional Info

Does your company only service US attendees?
Yes
Is your company a new exhibiting company?
Yes
         

For Marketing Opportunities offered by our partner TriStar, click here